The main goal of the EVE - EV Ecosystem for Theranostic Platforms consortium, which is funded by Business Finland and has a total of 13 partners, is to determine whether extracellular vesicles can be used in the diagnosis and treatment of CNS and cancer.
At Tampere University, the study is conducted by the Supramolecular Chemistry of Bio- and Nanomaterials team of the Chemistry and Advanced Materials Supramolecular Chemistry group. The research group is developing new methods and technologies to study how extracellular vesicles enter target cells and how they are transported within the cells.
Funding source
Business Finland
Contact persons
Elina Vuorimaa-Laukkanen
University Lecturer, kemiaFaculty of Engineering and Natural Sciences
Tampere University
phone number+358401981132
Hervanta Campus
Elina Vuorimaa-Laukkanen